Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Mesenchymal chondrosarcoma: clinicopathologic study of 20 cases.

Authors
Type
Published Article
Journal
Archives of Pathology & Laboratory Medicine
1543-2165
Publisher
Archives of Pathology and Laboratory Medicine
Publication Date
Volume
136
Issue
1
Pages
61–75
Identifiers
DOI: 10.5858/arpa.2010-0362-OA
PMID: 22208489
Source
Medline
License
Unknown

Abstract

Mesenchymal chondrosarcoma presents multiple challenges. Diagnostic pitfalls include inadequate biopsy samples, which may result in sample error. Sox9 has been proposed as a unique marker for mesenchymal chondrosarcoma which may improve diagnostic specificity. Treatment and prognosis vary considerably. Patients who receive surgery and chemotherapy seem to fare better. Multicenter studies with higher sample numbers may improve our understanding of this malignancy.

Statistics

Seen <100 times